2000 Canadians Wanted To Show Solution To Vitamin D Crisis

    "Vitamin D Deficiency Month" Kicks Off With New Campaign For Vitamin D
    Testing Called D(*)action

    TORONTO, Feb. 1 /CNW/ - Today, GrassrootsHealth, a consortium of
scientists, institutions and individuals committed to solving epidemic Vitamin
D deficiency worldwide, announced the kick-off of the Canadian leg of its new
D(*)action public health action program, targeting 2,000 Canadians to be a part
of a global Vitamin D study.
    The announcement comes on the first day of "Vitamin D Deficiency Month"
in Canada. By the end of February, an estimated 97 per cent of
sunlight-deprived Canadians will be Vitamin D deficient, according to
University of Calgary research.
    "It is time for action when it comes to the Vitamin D deficiency problem
in the world. We have read all the studies about the effects of a low serum
count. We now need Canadians to get tested and get their serum levels up to
the 40-60 ng/ml range," said Carole Baggerly, Director, GrassrootsHealth.
    Baggerly is a breast cancer survivor who is spreading the word about how
natural Vitamin D levels can decrease overall breast cancer risk by as much as
80 percent.
    GrassrootsHealth launched the D(*)action worldwide public health campaign
to address epidemic levels of Vitamin D deficiency by spreading the word
through D(*)action -- a testing, education and action campaign. Canadians who
join D(*)action will be tested two times per year during a 5 year program to
demonstrate the public health impact of Vitamin D, also known as the "Sunshine
    A Canadian IPSOS-Reid study commissioned last fall by D(*)action supporter
Dr. Marc Sorenson revealed that 91 per cent of Canadian women do not know
their Vitamin D blood levels, and only 21 percent say their physicians have
even discussed Vitamin D with them. Vitamin D deficiency is now linked to
significantly higher risk of most forms of cancer, as well as heart disease,
osteoporosis and multiple sclerosis.
    "Vitamin D deficiency is connected to a variety of disorders from the
basic winter "blahs" to over 30 varieties of Cancer," said Dr. Reinhold Vieth,
University of Toronto, Mt. Sinai Hospital and member of the GrassrootsHealth
group of scientists. "Canadians need to get tested and the D(*)action study will
allow us to further define what we all need to know about what it takes to get
to the recommended range (40-60 ng/ml).
    Dr. Vieth added, "Using public health statistics, we expect to see a
significant decrease in the incidence of diseases from breast cancer, colon
cancer, type 1 diabetes, hypertension and even the flu and colds. This is our
opportunity to put all this information together in an expedient manner with
the fastest public health impact."
    The D(*)action Scientists' Panel -- 30 worldwide expert Vitamin D
scientists -- recommends that the hydroxyvitamin D serum levels should be
between 40 and 60 ng/ml (100-150 nmol/L). The panel states that any risks of
Vitamin D inadequacy considerably exceed any risks of taking 2000 IU/day of
Vitamin D3, which the NAS-IOM regards as having no adverse health effect. For
a nominal fee, Canadians can be a part of a growing global movement to
eliminate epidemic levels of Vitamin D deficiency.
    "By focusing on the serum level where there is substantial agreement, we
easily take care of the difficulty inherent in recommending the dosage
required to reach that end-point. And the end-point is what's important --
dosage levels will vary considerable based on the individual, but the serum
level recommendations are the same," said Baggerly.

    Speaking Out On Vitamin D Deficiency

    As part of the D(*)action campaign, Dr. Vieth and Carole Baggerly are
available to present "Diagnosis & Treatment of Vitamin D Deficiency" seminars
about Vitamin D deficiency and D(*)action to health organizations, public health
associations, the public, cancer support groups and local communities across
    "We are helping Canadians to get tested and get educated - it is a
growing health crisis and costs the health care system billions of dollars
every year in addition to costing the individuals considerable pain, disease
and lowered quality of life," said Baggerly.

    How Canadians Can Get Tested

    GrassrootsHealth is sponsoring the use of blood spot test kits for a
$30.00 (USD) fee to each individual. The tests are to be done twice a year by
each individual along with the submission of some basic health data. The kits
are only available by participation in the study and sharing some health data.
A five year study will be conducted with the data accumulated from the
individuals tested to evaluate the results of the program in disease
prevention and to help create a long term plan for public health. Interim
results will be posted on www.grassrootshealth.net. The first group of results
showed that fully 60 per cent of the initial population was below the
recommended 40-60 ng/ml level.
    "New Vitamin D research is appearing on everything from autism to
diabetes dementia to osteoporosis and over 300 other diseases and disorders,"
said Dr. Vieth. "Participate in the study, get tested, get your serum levels
to the 40-60 ng/ml range and learn all you can about Vitamin D and how it
affects your health."

    About D(*)action

    The D(*)action project is an international public health project to solve
the Vitamin D deficiency epidemic. Currently, the project is in Japan, United
Kingdom, Australia, New Zealand, Japan and the United States. For more
information on joining the D(*)action study visit: www.grassrootshealth.net

For further information:

For further information: For media interviews and speaking engagements
please contact: Sarah Thompson, PUNCH Canada, (647) 837-1266,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890